Cadence Capital Management’s Exact Sciences EXAS Stock Holding History

Cadence Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-116,170	Closed	-$3.19M	–	620
2014 Q4	$3.19M	Buy	+116,170	New	+$2.83M	0.19%	152
2014 Q3	–	Sell	-44,865	Closed	-$764K	–	560
2014 Q2	$764K	Sell	44,865 -4,955	-10%	-$68.2K	0.04%	443
2014 Q1	$706K	Buy	+49,820	New	+$673K	0.03%	478

Other funds holding EXAS

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

JPCCM

J&P (China) Capital Management Hong Kong, China $586M AUM 82.64% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cadence Capital Management's EXAS Position: Q1 2015 in Review

Cadence Capital Management sold out of Exact Sciences (EXAS) in Q1 2015, closing a stake of 116,170 shares — an estimated $3.19M sold.

Cadence Capital Management first reported a position in EXAS in Q1 2014 and held it in 3 quarters. The position peaked at $3.19M in Q4 2014. 182 funds tracked by Wall St. Rank hold EXAS as of Q1 2015.

Cadence Capital Management reported no remaining Exact Sciences position as of Q1 2015 after selling out during the quarter.
Cadence Capital Management sold 116,170 Exact Sciences shares in Q1 2015, an estimated $3.19M.
Cadence Capital Management first reported a position in Exact Sciences in Q1 2014 and held it in 3 quarters.
Cadence Capital Management's Exact Sciences position peaked at $3.19M in Q4 2014.
182 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2015.

Based on Cadence Capital Management's 13F filing for Q1 2015, filed 30 Apr 2015.